Tamibarotene is a synthetic retinoid indicated for the treatment of relapsed or refractory acute promyelocytic leukemia. This therapeutic agent functions as a potent agonist of the nuclear retinoic acid… Read more
Tamibarotene is a synthetic retinoid indicated for the treatment of relapsed or refractory acute promyelocytic leukemia. This therapeutic agent functions as a potent agonist of the nuclear retinoic acid receptor, working through distinct mechanisms to induce cell differentiation and apoptosis in leukemic cells. To support the rigorous demands of pharmaceutical development, this category provides high-quality reference standards of Tamibarotene API, alongside its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential for accurate analytical testing, method validation, and impurity profiling. Laboratories utilize these precise standards to ensure the consistency and regulatory compliance of drug products, supporting critical quality control processes during the manufacturing and stability testing of retinoid-based therapies.